Patients previously experiencing gastrointestinal symptoms from GLP-1 receptor agonists, including nausea, vomiting, or abdominal distension, have a greater risk of increased residual gastric contents and should be treated as if they had a full stomach, regardless of fasting
Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
Peak concentration occurs within 12 to 72 hours after injection
Jenny Craig, Inc
Supporting Data: Studies show that protein-rich meals can increase GLP-1 secretion by 25-40%, depending on the protein type
Its also approved for weight management at higher doses under the brand name Wegovy